About the Opportunity Evren Technologies is a clinical-stage medical device company developing Phoenix —a first-of-its-kind, FDA-designated Breakthrough Device for the treatment of Post-Traumatic Stress Disorder (PTSD) using non-invasive transauricular vagus nerve stimulation (taVNS). As Phoenix advances toward FDA pivotal trials, we are entering a critical phase of clinical validation, system integration, and market readiness. PTSD affects more than 13 million Americans, yet current standards of care—largely pharmacologic and exposure-based therapies—often present limitations, including side effects, adherence challenges, and high discontinuation rates. Phoenix is designed to address this gap. Through a closed-loop, ear-level neuromodulation system, patients can receive safe, non-invasive, at-home treatment aimed at restoring autonomic nervous system balance. The platform is supported by clinical evidence, FDA Breakthrough Device Designation, and active collaboration across the VA,...